Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

COR Therapeutics, Inc. to Release / Webcast Third Quarter Financial Results Tuesday, October 17, 2000.


Business/Health Editors

SOUTH SAN FRANCISCO South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. , Calif.--(BW HealthWire)--Oct. 11, 2000

COR Therapeutics, Inc. (Nasdaq: CORR CORR

Used on the consolidated tape to indicate a correction in a reported transaction : CORR.LAST.GY 50 WAS 51.
) today said that its third quarter 2000 financial results will be released on Tuesday, October 17, at 8:00 a.m. Eastern Daylight Time (EDT EDT
abbr.
Eastern Daylight Time


EDT Eastern Daylight Time

EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York

EDT 
).

One-half hour later, at 8:30 a.m. EDT, as part of the Company's efforts to ensure full disclosure to all parties, COR Therapeutics will webcast a conference call live on the Company's internet site. The call will be led by Vaughn M. Kailian, President and Chief Executive Officer.

To access the live call or the 7-day archive, please log onto http://www.corr.com. Please connect to the Company's website prior to the conference call to ensure adequate time for any software download that may be needed to hear the webcast. Alternatively, the webcast may be accessed by logging on to http://www.vcall.com/NASApp/VCall/EventPage?ID=43401.

COR Therapeutics, Inc. is dedicated to the discovery, development, and commercialization of novel pharmaceutical products for the treatment and prevention of severe cardiovascular diseases. COR has complementary research and development programs that seek to address critical needs in severe cardiovascular care, including unstable angina, acute myocardial infarction acute myocardial infarction (·kyōōtˑ mī·ō·karˑ·dē· , deep vein thrombosis A blood clot (thrombos) in a vein deep within the muscle, typically in the thigh or calf. It is caused by disease or the lack of activity such as sitting for hours at a computer screen. , and restenosis.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Oct 11, 2000
Words:205
Previous Article:Datalink.net and Application Design Associates to Deliver Wireless Messaging to the Bottling Industry.
Next Article:U. S. Plastic Lumber Corp. Announces Product Returns Resulting in a Q3 Loss and Appointment of Banc of America Securities LLC as a Financial Advisor.
Topics:



Related Articles
iPrint.com, COR Therapeutics, Artesyn Technologies, Cypress Semiconductor, and Dal-Tile International Conference Calls to be Broadcast On Investor...
COR Therapeutics, Inc. Announces Increased Sales of INTEGRILIN -eptifibatide- Injection and Third Quarter 2000 Financial Results.
COR Therapeutics, Inc. to Report / Webcast Fourth Quarter 2000 Financial Results Tuesday, January 23, 2001.
COR Therapeutics, Inc. to Report / Webcast First Quarter 2001 Financial Results Tuesday, April 17, 2001.
COR Therapeutics, Inc. Reports First Quarter 2001 Financial Results.
COR Therapeutics, Inc. to Report / Webcast Second Quarter 2001 Financial Results Tuesday, July 17, 2001.
COR Therapeutics, Inc. Reports Profitable Second Quarter Driven by 60 Percent Year-Over-Year INTEGRILIN Sales Growth.
COR Therapeutics, Inc. Resets Guidance for Third Quarter and Year-End 2001.
COR Therapeutics, Inc. to Report / Webcast Third Quarter 2001 Financial Results Wednesday, October 24, 2001.
COR Therapeutics, Inc. Reports Profitable Third Quarter.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles